(Total Views: 88)
Posted On: 12/12/2022 11:50:49 AM
Post# of 144774
$PRTA News Article - Prothena Presents Data Demonstrating Consistent Survival Benefit Observed with Birtamimab in Mayo Stage IV AL Amyloidosis Patients in Phase 3 VITAL Study at ASH 2022 https://marketwirenews.com/news-releases/prot...00890.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
